medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2000, Number 2

<< Back Next >>

Perinatol Reprod Hum 2000; 14 (2)

Manejo intravenoso en pediatría y sus complicaciones infecciosas: definición del problema y propuesta de solución

Macías AE, Hernández J, Cortés G, Hernández I, Muñoz JM, Landin G, Medina H

Language: Spanish
References: 46
Page: 98-107
PDF size: 190.72 Kb.


ABSTRACT

Everyday intravenous (IV) therapy leads to significant infectious risks; these are higher in developing countries due to lapses while handling IV drugs and fuids (admixtures under improper conditions). Hospital personnel are usually not aware of the potential risks because blood cultures are not performed routinely and bacteremia occurs unnoticed. Catheter-related bacteremia is generally caused by staphylococci and prevention is achieved using proper insertion techniques. However, in pediatric wards from developing countries, Klebsiella, Enterobacter, or Serratia, usually cause nosocomial bacteremia, which grow well in parenteral solutions. From the 5% extrinsic contamination rate observed in Mexican studies, these organisms have been found in more than 60% of the cases. It is important to stress that the highest contamination rates ocurr in neonatal units (30%), which could be associated to high mortality (up to 33%). Excessive academic calculations induce unneeded manipulation of homemade solutions regardless the potential microbiologic dangers. This paper is a simplified proposal for the management of IV infusions, tailored to avoid these risks.


REFERENCES

  1. Avila-Figueroa C, Cashat-Cruz M, Aranda-Patrón E et al. Prevalencia de infecciones nosocomiales en niños: encuesta de 21 hospitales en México. Salud Pública Mex 1999; 41: S18-S25.

  2. Pearson M. The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular-device-related infections. Infection Control Hosp Epidemiol 1996;17:438-73.

  3. Choukair MK. Fluids and electrolytes. En: Siberry GK, Iannone R (eds.). The Harriet Lane Handbook. 15ª ed. Mosby, 2000: 229-50.

  4. Adelman RD, Solhaug MJ. Pathophysiology of body fluids and fluid therapy. En: Behrman RD, Kliegman RM, Jenson HB (eds.). Nelson Textbook of pediatrics. 16ª ed. Philadelphia Pennsylvania: W.B. Saunders Company. 2000: 189-227.

  5. Avila Figueroa C, Hernández Ramos I, Nandí E, Goldamnn DA, Huskins WC. Survey of evidencebased practices for the prevention of device-associated infections in pediatric and neonatal intensive care units in public hospitals in Mexico. Presentado en: CDC 4th Decennial International Conference on Nosocomial and Healthcare-associated Infections. Atlanta Georgia, 2000: 262.

  6. Johnson RA, Zajac RA, Evans ME. Suppurative thrombophlebitis: correlation between pathogen and underlying disease. Infect Control 1986; 7: 582-85.

  7. Maki DG, Ringer M. Risk factors for infusionrelated phlebitis with small peripheral venous catheters. Ann Intern Med 1991;114: 845-54.

  8. Collin J, Collin C, Constable FL et al. Infusion phlebitis and infection with various cannulas. Lancet 1975; 2: 150-53.

  9. Macías-Hernández AE, Cortés-Gallo G, Muñoz-Barrett JM et al. Contaminación de catéteres endovenosos en un servicio pediátrico. Bol Med Hosp Infant Mex 1994; 51: 524-26.

  10. Ponce de León RS, Baridó E, Rangel-Frausto S et al. Manual de prevención y control de infecciones hospitalarias. México D.F.: Obsidiana, S.A. de C.V., 1995.

  11. Sheretz RJ. Surveillance for infections associated with vascular catheters. Herwaldt LA, Decker MD (eds.). A practical handbook for hospital epidemiologists. The Society for Healthcare Epidemiology of America. SLACK 1998: 115-23.

  12. Armstrong CW, Mayhall CG, Miller KB et al. Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol 1990; 11: 71-8.

  13. Maki DG. Infections due to infusion therapy. En: Bennett JV, Brachman PS, Sanford JP (eds.). Hospital infections. Boston: Little, Brown and Company. 1992: 849-92.

  14. Wey SB, Mori M, Pfaller MA et al. Hospitalacquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642-45.

  15. Maki, DG. Nosocomial bacteriemia. Am J Med 1981;70:183-96.

  16. Maki, DG. Infections caused by intravascular devices used for infusion therapy: Pathogenesis, prevention and management. En: Bisno AL, Waldvogel, FA (eds.). Infections associated with indwelling medical devices. 2nd edition. Washington DC: ASM press, 1994.

  17. Pérez Delgadillo M, Cashat Cruz M, Avila Figueroa C. Infecciones relacionadas a catéteres intravasculares. Bol Med Hosp Infant Mex 1998; 55(6): 341-46.

  18. Landers S, Moise AA, Fraley JK et al. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991; 145: 657-80.

  19. Banerjee SN, Emori G, Culver DH et al. Secular trends in nosocomial primary blood-stream infections in the United States, 1980-1989. Am J Med 1991; 91(Suppl 3B): S86-S9.

  20. Faubion WC, Wesley JR, Khalidi N et al. Total parenteral nutrition catheter sepsis: impact of the team approach. J Parent Enteral Nutr 1986; 10: 642-45.

  21. Meier PA, Fredrickson M, Catney M, Nettleman MD. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. Am J Infect Control 1998; 26: 388-92.

  22. Volkow P, Sanchez MG, Lazo de la Vega S et al. Experience of an intravenous therapy team at the Instituto Nacional de Cancerología de México with a long lasting low cost silastic venous catheters. Clin Infect Dis 1994; 18: 719-25.

  23. Doebbeling BN, Stanley GL, Sheetz CT et al. Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327: 88-93.

  24. Abi-Said D, Raad I, Umphrey J et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 1999; 20: 101-5.

  25. Raad II, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-38.

  26. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and clorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.

  27. Donowitz LG. Benzalkonium chloride is still in use. Infect Control Hosp Epidemiol 1991; 12: 186-87.

  28. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996; 24: 313-42.

  29. Raad I. Intravascular catheter related infections. Lancet 1998; 351: 893-98.

  30. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusion. J Infect Dis 1975; 131: 267-72.

  31. Crichton EP. Infusion fluids as culture media. Am J Clin Pathol 1973; 59: 199-202.

  32. Michaels L, Ruebner B. Growth of bacteria in intravenous infusion fluids. Lancet 1953; 1: 772-74.

  33. Macías-Hernández AE, Hernández Ramos I, Muñoz Barrett JM et al. Pediatric primary Gram-negative nosocomial bacteriemia: a possible relationship with infusate contamination. Infect Control Hosp Epidemiol 1996; 17: 276-80.

  34. Macías AE, Muñoz JM, Bruckner DA et al. Parenteral infusions bacterial contamination in a multiinstitutional survey in Mexico: Considerations for nosocomial mortality. Am J Infect Control 1999; 27: 285-90.

  35. Maki DG, Rhame FS, Mackel DC et al. Nationwide epidemic of septicemia caused by contaminated intravenous products. Epidemiologic and clinical features. Am J Med 1976; 60: 471-85.

  36. Gorbea HF. Intravenous tubing with burettes can be safely changed at 48-hours intervals. JAMA 1984; 251: 2112-15.

  37. Lai KK. Safety of prolonging peripheral cannula and IV tubing use from 72 hours to 96 hours. Am J Infect Control 1998; 26: 66-70.

  38. Maki DG, Botticelli JC, LeRoy ML et al. Prospective study of replacing administration sets for intravenous therapy at 48- vs. 72-hours intervals. JAMA 1987; 258: 1777-81.

  39. Maki DG, Klein BS, McCormick RD et al. Nosocomial Pseudomonas picketti bacteriemias traced to narcotic tampering: a case for selective drug screening of health care personnel. JAMA 1991; 265: 981-86.

  40. Macías-Hernández AE, Ortega-González P, Muñoz-Barrett JM et al. Bacteriemia nosocomial pediátrica. El cultivo de soluciones parenterales puede ayudar en su control. Rev Invest Clin 1994; 46: 295-300.

  41. Hernández Ramos I, Gaytán Meza J, Romero D, Hernández M, Avila C. Contaminación de soluciones parenterales en pediatría. Enf Infec y Microbiol 1998; 18(3): 100-101.

  42. Pegues DA, Arathoon EG, Samayoa B et al. Epidemic gram-negative bacteriemia in a neonatal unit in Guatemala. Am J Infect Control 1994; 22: 163-71.

  43. Zaidi M, Sifuentes J, Bobadilla M et al. Epidemic Serratia marcescens bacteriemia and meningitis in a neonatal unit of Mexico city. Infect Control Hosp Epidemiol 1989; 10: 14-20.

  44. Jarvis WR, Cookson ST, Robles B. Prevention of nosocomial bloodstream infections: a national and international priority. Infect Control Hosp Epidemiol 1996; 17: 272-75.

  45. Bennett SN, McNeill MM, Bland LA et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333; 147-54.

  46. León RA, Llausas ME, Pérez PV, Morales BC, Cruz FM, Muro AS. Bacteriemia por Klebsiella ozanae debida a contaminación de soluciones parenterales en una Unidad de Cuidados Intensivos Neonatales. Reporte de un brote. Enf Infecc y Microbiol 1998: 18: S34.




2020     |     www.medigraphic.com